Senior A E, Bhagat S
Department of Biochemistry and Biophysics, University of Rochester Medical Center, New York 14642, USA.
Biochemistry. 1998 Jan 20;37(3):831-6. doi: 10.1021/bi9719962.
P-Glycoprotein (Pgp) (also known as multidrug-resistance protein) contains two nucleotide binding sites, both of which are catalytic ATPase sites. The covalent reagent 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) reacts in catalytic sites, and full inactivation of ATPase activity occurs at a reaction stoichiometry of 1 mol of NBD-Cl/mol of Pgp. We show that, at reaction stoichiometry of < or = 1 mol/mol, both nucleotide sites become labeled in relatively nonselective fashion. There is therefore strong interaction between the two nucleotide sites because (a) reaction of one site with NBD-Cl severely impedes reaction of reagent with the other site, and (b) reaction of one site inhibits steady-state ATPase, i.e. both sites are inhibited. Vanadate-trapping experiments revealed that when one nucleotide site was reacted with NBD-Cl, not even a single ATPase turnover event could occur in the other, intact, nucleotide site. The data demonstrate therefore that catalytic cooperativity between the two nucleotide sites in Pgp is extremely strong and mandatory for catalysis.
P-糖蛋白(Pgp)(也称为多药耐药蛋白)含有两个核苷酸结合位点,这两个位点均为催化性ATP酶位点。共价试剂7-氯-4-硝基苯并-2-恶唑-1,3-二氮杂茂(NBD-Cl)在催化位点发生反应,当反应化学计量比为1摩尔NBD-Cl/摩尔Pgp时,ATP酶活性完全失活。我们发现,当反应化学计量比≤1摩尔/摩尔时,两个核苷酸位点都会以相对非选择性的方式被标记。因此,两个核苷酸位点之间存在强烈的相互作用,原因如下:(a)一个位点与NBD-Cl反应会严重阻碍试剂与另一个位点的反应;(b)一个位点的反应会抑制稳态ATP酶,即两个位点均被抑制。钒酸盐捕获实验表明,当一个核苷酸位点与NBD-Cl反应时,另一个完整的核苷酸位点甚至无法发生一次ATP酶周转事件。因此,数据表明Pgp中两个核苷酸位点之间的催化协同作用极强,且对于催化作用是必不可少的。